Hence, a diagnosis of sarcopenia can be an early indication for the AD onset and related biomarkers including the identification of NFL amount from CSF samples [37] or muscle biopsies [4] can become valid tools for the prediction of an AD clinical course. Here, NEFL is linked to sarcopenia.